UWM
GTHX

Urban Wealth Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Urban Wealth Management’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$18K Buy
+3,658
New +$20.3K 0.06% 156

Other funds holding GTHX

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Urban Wealth Management's GTHX Position: Q2 2022 in Review

Urban Wealth Management opened a new position in G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2022: 3,658 shares worth $18K. The stake represents 0.06% of the portfolio and ranks #156 among its holdings.

98 funds tracked by Wall St. Rank hold GTHX as of Q2 2022.

  • Urban Wealth Management held 3,658 shares of G1 Therapeutics, Inc. Common Stock worth $18K as of Q2 2022.
  • G1 Therapeutics, Inc. Common Stock was a new Urban Wealth Management position in Q2 2022.
  • G1 Therapeutics, Inc. Common Stock made up 0.06% of Urban Wealth Management's portfolio in Q2 2022, its #156 holding.
  • 98 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Urban Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.